View Older Stories View More Recent Stories

Feb 11, 2016 04:39PM Form SC 13G Ophthotech Corp. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:37PM Form SC 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:35PM Form SC 13G/A NEUROCRINE BIOSCIENCES Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G MAGELLAN HEALTH INC Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:31PM Form SC 13G/A Mirati Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:29PM Form SC 13G/A MEI Pharma, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2016 04:28PM Form SC 13G/A MOLINA HEALTHCARE INC Filed by: ORBIMED ADVISORS LLC
Jan 11, 2016 08:00AM Adimab Provides Update on Recent Partnerships and Milestones
Jan 6, 2016 06:00AM NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Dec 24, 2015 08:43AM OrbiMed Advisors Sells Nearly 500K Shares of RELYPSA (RLYP); Still Has Significant 17.75% Stake
Dec 24, 2015 08:36AM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Dec 23, 2015 05:06PM Form 4 Relypsa Inc For: Dec 21 Filed by: ORBIMED ADVISORS LLC
Dec 16, 2015 01:01AM Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
Dec 14, 2015 06:00AM Viralytics Completes $28 million Placement -- SPP to Follow
Nov 30, 2015 06:56PM Form 4 Otonomy, Inc. For: Nov 25 Filed by: ORBIMED ADVISORS LLC
Nov 25, 2015 02:26PM Form SC 13D/A Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 20, 2015 11:17AM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Nov 19, 2015 03:58PM Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 19, 2015 11:58AM Neurostimulation Established as a Treatment Option for Sleep Apnea Patients Who Do Not Tolerate CPAP
Nov 19, 2015 08:20AM Conference Forum's Immuno-Oncology 360° Announces the Support of Key Partnerships to Present Multiple Views to Advance IO as a Standard of Cancer Treatment
Nov 19, 2015 06:01AM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
Nov 13, 2015 04:17PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 11, 2015 04:27PM Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
Nov 10, 2015 09:00AM Inspire Medical Systems to Present at Three Upcoming Investor Conferences
Nov 6, 2015 04:35PM Form SC 13D Dimension Therapeutics, Filed by: ORBIMED ADVISORS LLC
Oct 30, 2015 05:14PM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Oct 20, 2015 02:25PM Healthbox Returns to Israel to Accelerate Entrepreneurs' Access to the US Market
Oct 14, 2015 03:50PM EY and SolomonEdwards honor the 2015 Venture Capital Award of Excellence winners
Oct 14, 2015 08:00AM The Galien Foundation Announces Partnership with Business France to Foster US-France Life Sciences Innovation via MedStartUp Program
Oct 13, 2015 04:02PM Form 4 Sientra, Inc. For: Oct 12 Filed by: ORBIMED ADVISORS LLC
Oct 9, 2015 07:50PM Form 4 Sientra, Inc. For: Oct 07 Filed by: ORBIMED ADVISORS LLC
Oct 6, 2015 07:34PM Form 4 Sientra, Inc. For: Oct 02 Filed by: ORBIMED ADVISORS LLC
Oct 6, 2015 01:04PM Onxeo Announces Evolution in the Board of Directors
Oct 5, 2015 03:23PM TytoCare Hires Jeff Cutler to Lead Commercial Launch of its Remote Home Exam Platform
Oct 2, 2015 05:26PM Form SC 13D Nabriva Therapeutics AG Filed by: ORBIMED ADVISORS LLC
Oct 1, 2015 05:56PM Form 4 Sientra, Inc. For: Sep 29 Filed by: ORBIMED ADVISORS LLC
Sep 29, 2015 05:25PM U.S. biotech bloodbath hits hedge funds but some bargains emerge
Sep 21, 2015 03:39PM Biotech stocks sink after Hillary Clinton 'price gouging' tweet
Sep 8, 2015 07:00AM ContraFect Appoints Key Business Executives
Sep 4, 2015 04:36PM Form SC 13G/A Biotie Therapies Corp. Filed by: ORBIMED ADVISORS LLC
Aug 17, 2015 04:41PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Aug 14, 2015 04:24PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2015 04:07PM Xtant Medical Reports First Half 2015 Financial Results
Aug 12, 2015 04:07PM Xtant Medical Reports First Half 2015 Financial Results
Aug 6, 2015 09:00AM Avitide, Inc., Secures Series C Financing to Expand On-demand Biopharmaceutical Affinity Purification Platform and Achieve Profitability
Jul 9, 2015 04:24PM Form SC 13D PIERIS PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Jul 8, 2015 08:00AM Pieris to Receive Seventh Milestone Payment From Daiichi Sankyo Collaboration to Develop Anticalin(R) Therapeutics
Jul 2, 2015 04:43PM Form SC 13G Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
Jun 26, 2015 04:58PM Form SC 13G Biotie Therapies Corp. Filed by: ORBIMED ADVISORS LLC
Jun 23, 2015 09:32AM Clementia Pharmaceuticals Raises U.S. $60 Million in Mezzanine Financing to Support Development of Palovarotene for Fibrodysplasia Ossificans Progressiva
View More Recent Stories View Older Stories